Press Releases

Stay Updated

Press Releases

STATEMENT: Patients For Affordable Drugs Responds To AbbVie Pharmaceuticals Lawsuit To Stop Medicare Negotiation

Marks the 11th lawsuit filed by Big Pharma and its allies to undermine Medicare Drug Price Negotiation at the expense of patients WASHINGTON, D.C. — Just two weeks after Botox and Botox Cosmetic were named as drugs to be included in the third round of Medicare Drug Price Negotiations, manufacturer AbbVie, has filed a lawsuit in the U.S. District Court […]

Press Releases

STATEMENT: CMS Announces 15 Drugs Selected for Round 3 of Medicare Drug Price Negotiation

Drugs included in Round 3 are used by nearly 1.8 million people on Medicare and accounted for $27 billion in Medicare spending WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) has released the list of the next 15 high-priced medications selected for Medicare Drug Price Negotiation, along with one drug selected for […]

Press Releases

Remembering David Mitchell: A Distinguished Life In Service to Others

WASHINGTON, D.C. — Today, we honor the life, legacy, and friendship of David Mitchell – a tireless public health leader and the founder of Patients For Affordable Drugs – who died on Friday, January 2, 2026. Below is a statement from Chuck Hurley, David’s great friend and Board Chair of Patients For Affordable Drugs, reflecting on […]

Press Releases

Solicitor General Urges Supreme Court to Deny Review of AstraZeneca’s Challenge to Medicare Drug Price Negotiation

WASHINGTON, D.C. — The Solicitor General’s office filed a brief urging the Supreme Court to deny AstraZeneca’s petition challenging the constitutionality of the Medicare Negotiation Program, forcefully defending the program and rejecting the drugmaker’s claims outright. The filing responds to AstraZeneca’s effort to overturn a 2024 appeals court ruling that upheld the program. The petition […]

Press Releases

Medicare’s First Negotiated Drug Prices Take Effect: a Win for Patients

Patients on Medicare begin seeing an average list price reduction of 63% percent on the first 10 blockbuster drugs starting January 1st WASHINGTON, D.C. — Today marks a historic milestone for prescription drug affordability in the United States. For the first time in Medicare’s history, lower negotiated prices for 10 of the most expensive and widely used prescription […]

Press Releases

Statement on the Retirement of David Mitchell, Founder and President of the Board of Patients For Affordable Drugs

WASHINGTON, D.C. — Patients For Affordable Drugs has released the following statement on the retirement of its Founder and President of the Board, David Mitchell. “After 15 years living with cancer and in continuous treatment, David Mitchell is stepping down as President of the Board and retiring from Patients For Affordable Drugs to focus on his health […]

Press Releases

Pharma Loses for 16th Time: DC District Court Rejects Teva Pharmaceuticals’ Challenge to Medicare Negotiation

WASHINGTON, D.C. — Today, the U.S. District Court for the District of Columbia rejected Teva Pharmaceuticals’ challenge to the Medicare Drug Price Negotiation Program — marking the 16th defeat against the industry’s nationwide legal campaign to prevent the law from lowering prices. Teva manufactures Austedo and Austedo XR — used to treat involuntary movements associated […]

Press Releases

Pharma’s Losing Streak In Court Continues: Novo Nordisk’s Appeal Rejected

Bipartisan panel of judges unanimously rejects industry’s recycled arguments as lower drug prices draw closer for millions of patients WASHINGTON, D.C. — In yet another blow to Big Pharma’s nationwide legal campaign against Medicare Negotiation, the U.S. Court of Appeals For The Third Circuit unanimously rejected Novo Nordisk’s challenge to the program this morning — marking the 15th legal defeat for […]